绿叶制药(02186)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02186 绿叶制药

未开盘 12-12 16:08:09

2.940

+0.060

+2.08%

最高2.940	最低2.850	成交量2,345万
今开2.880	昨收2.880	日振幅3.13%
总市值117.45亿	流通市值117.45亿	总股本39.95亿
成交额6,786万	换手率0.59%	流通股本39.95亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02186","market":"HK","secType":"STK","nameCN":"绿叶制药","latestPrice":2.94,"timestamp":1765526889002,"preClose":2.88,"halted":0,"volume":23454500,"delay":0,"floatShares":3995000000,"shares":3995000000,"eps":0.13837914376370677,"marketStatus":"未开盘","change":0.06,"latestTime":"12-12 16:08:09","open":2.88,"high":2.94,"low":2.85,"amount":67862887,"amplitude":0.03125,"askPrice":2.94,"askSize":620500,"bidPrice":2.93,"bidSize":1044500,"shortable":3,"etf":0,"ttmEps":0.11637769275037715,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":0,"adr":0,"listingDate":1404835200000,"exchange":"SEHK","adjPreClose":2.88,"openAndCloseTimeList":[[1765503000000,1765512000000],[1765515600000,1765526400000]],"volumeRatio":1.3174983007902406,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02186","defaultTab":"news","newsList":[{"id":"2590502730","title":"绿叶制药(02186)附属完成发行150万股可交换优先股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590502730","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590502730?lang=zh_cn&edition=full","pubTime":"2025-12-12 22:43","pubTimestamp":1765550599,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿叶制药(02186)发布公告，于2025年12月12日，根据认购协议的条款，可交换优先股的发行已完成。发行人Luye Geneora Holding Limited(本公司的全资附属公司)已向认购人配发及发行150万股可交换优先股。该等可交换优先股可交换为本集团所持博安生物的现有股份，并不涉及博安生物发行任何新股份。按初始交换价11.718港元计算，于交换所有可交换优先股后可交付的博安生物股份总数最高为100,486,431股，截至本公告日期，占博安生物已发行股份总数约16.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02186","BK1583","BK1606"],"gpt_icon":0},{"id":"2591636302","title":"每日卖空追踪 | 绿叶制药 12月12日卖空量成交69.15万股，卖空比例为2.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591636302","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591636302?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:30","pubTimestamp":1765528226,"startTime":"0","endTime":"0","summary":"绿叶制药北京时间12月12日，涨2.08%，卖空量成交69.15万股，较上一交易日减少75.95%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212165430a69b83cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212165430a69b83cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02186","BK1583","BK1191","BK1606"],"gpt_icon":0},{"id":"2589789331","title":"每日卖空追踪 | 绿叶制药 12月08日卖空量成交90.25万股，卖空比例为4.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589789331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589789331?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:30","pubTimestamp":1765182626,"startTime":"0","endTime":"0","summary":"绿叶制药北京时间12月08日，涨1.33%，卖空量成交90.25万股，较上一交易日增加28.56%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163410a72aaf27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163410a72aaf27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","02186","BK1191","BK1583"],"gpt_icon":0},{"id":"2589312723","title":"绿叶制药12月08日主力净流入89.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2589312723","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589312723?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:15","pubTimestamp":1765181741,"startTime":"0","endTime":"0","summary":"12月08日, 绿叶制药股价涨1.33%，报收3.05元，成交金额6019.5万元，换手率0.49%，振幅3.65%，量比1.90。绿叶制药今日主力资金净流入89.9万元，上一交易日主力净流出140.3万元。该股近5个交易日下跌0.33%，主力资金累计净流出955.7万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出515.4万元，其中净流出天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120816185897960b55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120816185897960b55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","BK1606","02186"],"gpt_icon":0},{"id":"2589807750","title":"港股异动 | 绿叶制药(02186)涨近3% 米美欣®等五款新品获纳入国家医保药品目录或商保创新药目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589807750","media":"智通财经","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589807750?lang=zh_cn&edition=full","pubTime":"2025-12-08 09:48","pubTimestamp":1765158517,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，绿叶制药涨近3%，截至发稿，涨2.66%，报3.09港元，成交额837.51万港元。消息面上，12月7日，绿叶制药发布公告，集团共有五款新产品成功纳入由国家医疗保障局发布的《国家基本医疗保险、生育保险和工伤保险药品目录》或《商业健康保险创新药品目录》。该五款新产品包括：米美欣、瑞百莱首次纳入国家医保药品目录；赞必佳成功入选商保创新药目录；百拓维、瑞可妥顺利续约，继续被纳入国家医保药品目录。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378607.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","06978","BK1606","BK1574","159992","BK1161","BK1583","02186"],"gpt_icon":0},{"id":"2589887431","title":"绿叶制药(02186)五款新产品成功纳入2025年国家医保药品目录或商保创新药目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589887431","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589887431?lang=zh_cn&edition=full","pubTime":"2025-12-07 18:43","pubTimestamp":1765104213,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿叶制药(02186)发布公告，集团共有五款新产品成功纳入由国家医疗保障局发布的《国家基本医疗保险、生育保险和工伤保险药品目录(2025年)》(国家医保药品目录)或《商业健康保险创新药品目录(2025年)》(商保创新药目录)。该五款新产品包括：米美欣®(羟考酮纳洛酮缓释片)、瑞百莱®(棕榈酸帕利哌酮注射液(Ⅱ))首次纳入国家医保药品目录;赞必佳®(注射用芦比替定)成功入选商保创新药目录;百拓维®(注射用戈舍瑞林微球)、瑞可妥®(注射用利培酮微球(Ⅱ))顺利续约，继续被纳入国家医保药品目录。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378506.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1161","BK1191","BK1606","159992","BK1574","06978","02186"],"gpt_icon":0},{"id":"2588688188","title":"拜耳降价，齐鲁秒跟，却打中了绿叶制药的“七寸”","url":"https://stock-news.laohu8.com/highlight/detail?id=2588688188","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588688188?lang=zh_cn&edition=full","pubTime":"2025-12-04 19:41","pubTimestamp":1764848486,"startTime":"0","endTime":"0","summary":"但拜耳和齐鲁这轮降价，却正好打中了 绿叶制药 的七寸。11月26日， 绿叶制药 子公司 博安生物 的阿柏西普生物类似药获批上市，成为国内第二个获批的产品。齐鲁制药是最先成功的。2023年12月，齐鲁制药阿柏西普生物类似药获批上市。2024年8月，齐鲁拿下了雷珠单抗国内首个生物类似药。9月30日，RC28已经申报上市，用于治疗糖尿病黄斑水肿，预计不久后就将加入眼底病用药的“战场”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204194908a4cc968e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204194908a4cc968e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU2328871848.SGD","BK1606","09995","LU1969619763.USD","BK1161","01801","BK1191","02186","BK1574"],"gpt_icon":0},{"id":"2589857257","title":"每日卖空追踪 | 绿叶制药 12月04日卖空量成交57.8万股，卖空比例为6.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589857257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589857257?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837029,"startTime":"0","endTime":"0","summary":"绿叶制药北京时间12月04日，涨1%，卖空量成交57.8万股，较上一交易日减少73.49%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163426978f87fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163426978f87fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","BK1606","02186"],"gpt_icon":0},{"id":"1129263395","title":"绿叶制药（02186）更新11月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1129263395","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129263395?lang=zh_cn&edition=full","pubTime":"2025-12-03 17:35","pubTimestamp":1764754548,"startTime":"0","endTime":"0","summary":"绿叶制药集团有限公司于2025年12月3日更新披露截至2025年11月30日的股份变动月报表，显示报告期内公司股本维持稳定，未有新增发行及股份回购活动。公司资料显示，其法定股本为10,000,000,000股普通股，面值USD 0.02，法定股本总额USD 200,000,000，报告期内无变动。已发行股本方面，截至11月底，公司普通股已发行股份3,994,515,953股，与上月底持平，无库存股。绿叶制药确认，11月的所有股本变动事项均遵守香港联交所《上市规则》及相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"gpt_icon":0},{"id":"2588766440","title":"每日卖空追踪 | 绿叶制药 12月03日卖空量成交48.1万股，卖空比例为3.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588766440","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588766440?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:30","pubTimestamp":1764750625,"startTime":"0","endTime":"0","summary":"绿叶制药北京时间12月03日，跌0.66%，卖空量成交48.1万股，较上一交易日减少64.41%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163421a4c9efc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163421a4c9efc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","BK1583","02186","BK1191"],"gpt_icon":0},{"id":"2588007664","title":"绿叶制药12月03日遭主力抛售441.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588007664","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588007664?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:15","pubTimestamp":1764749723,"startTime":"0","endTime":"0","summary":"12月03日, 绿叶制药股价跌0.66%，报收3.01元，成交金额4021.5万元，换手率0.33%，振幅1.98%，量比1.13。绿叶制药今日主力资金净流出441.9万元，连续5日净流出，上一交易日主力净流出442.0万元。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为66.67%，平均跌幅为1.45%。该股近5个交易日下跌3.54%，主力资金累计净流出2637.5万元；近20日主力资金累计净流出609.8万元，其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203161656a4c9e407&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203161656a4c9e407&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02186","BK1583","BK1606"],"gpt_icon":0},{"id":"2588048052","title":"260亿阿尔茨海默症药物研发：机遇与荆棘并存","url":"https://stock-news.laohu8.com/highlight/detail?id=2588048052","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588048052?lang=zh_cn&edition=full","pubTime":"2025-12-03 11:34","pubTimestamp":1764732885,"startTime":"0","endTime":"0","summary":"在阿尔茨海默症领域，药企纷纷布局。LY03017拟用于治疗阿尔茨海默病精神病性障碍、帕金森病精神病性障碍、精神分裂症阴性症状。公司相关人士表示，此次试验失败可能成为 “为其产品用于阿尔茨海默病治疗钉上的一颗棺材钉”。阿尔茨海默症的发病机制复杂且尚未完全明确，这使得药物研发如同在迷雾中航行，每一步都充满未知与风险。从药企的积极探索到国际头部的研发受挫，AD药物领域的攻坚之路清晰地呈现出机遇与荆棘并存的态势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203113905978d08c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203113905978d08c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","BK1606","02186"],"gpt_icon":0},{"id":"2586130787","title":"11月生物类似药接连获批！涉及绿叶制药、复宏汉霖等","url":"https://stock-news.laohu8.com/highlight/detail?id=2586130787","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586130787?lang=zh_cn&edition=full","pubTime":"2025-11-28 15:07","pubTimestamp":1764313628,"startTime":"0","endTime":"0","summary":"2025年11月27日，中国生物医药领域传来重磅消息：绿叶制药集团控股子公司博安生物自主研发的博优景正式获得国家药品监督管理局上市批准。生物类似药的研发并非简单复制，而是对原研药质量、安全性和有效性的全面匹配。从临床需求出发，以技术创新为核心，我国生物类似药核心价值不断凸显。业内表示，特别是以贝伐珠单抗、利妥昔单抗、阿达木单抗为代表的用于肿瘤、自身免疫性疾病的生物类似药，临床需求量大。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128150952951f3459&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128150952951f3459&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","02696","HK0000165453.HKD","02186","BK1583","BK1161","BK1191"],"gpt_icon":0},{"id":"2586787916","title":"又一款国产新药获美国FDA特殊豁免资格！","url":"https://stock-news.laohu8.com/highlight/detail?id=2586787916","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586787916?lang=zh_cn&edition=full","pubTime":"2025-11-28 10:38","pubTimestamp":1764297504,"startTime":"0","endTime":"0","summary":"近日，美国FDA正式授予睿健毅联医药科技有限公司旗下NouvNeu004注射液“Special Exemption”特殊豁免资格，并进一步批准NouvNeu004注射液针对多系统萎缩的国际I期临床试验。今年以来，国内已有多款处于研发中的创新药物获得该特殊批准。2025年，多款中国创新药获 FDA 特殊豁免，不仅证明了企业的研发能力，也彰显了当前中国医药产业正加速从仿制药大国向创新药强国跨越。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511281045259783dae0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511281045259783dae0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1606","02186","BK1191"],"gpt_icon":0},{"id":"2586990296","title":"智通港股通资金流向统计(T+2)|11月27日","url":"https://stock-news.laohu8.com/highlight/detail?id=2586990296","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586990296?lang=zh_cn&edition=full","pubTime":"2025-11-27 07:31","pubTimestamp":1764199861,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，11月24日,阿里巴巴-W、腾讯控股、快手-W南向资金净流入金额位列市场前三，分别净流入40.60 亿、11.68 亿、8.17 亿中芯国际、中国海洋石油、华虹半导体南向资金净流出金额位列市场前三，分别净流出-10.33 亿、-3.80 亿、-3.36 亿在净流入比方面，途虎-W、越秀交通基建、华润饮料以65.44%、57.38%、53.66%位列市场前三。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374206.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00941","01157","00981","02186","01347","03918","00990","02600","01052","06963","81810","00489","89988","HMTD.SI","HBBD.SI","02899","03618","METmain","MIUmain","01330","02039","02460","02609","09988","HXXD.SI","01024","09690","01921","03033","01336","HKXCY","01801","00388","03441","03306","02172","03968","00991","00883","00700","02016","HEXmain","01375","01579"],"gpt_icon":1},{"id":"2586499289","title":"港股异动 | 绿叶制药(02186)涨超3% 新药LY03017在美国获准开展临床试验 拟用于治疗PDP等","url":"https://stock-news.laohu8.com/highlight/detail?id=2586499289","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586499289?lang=zh_cn&edition=full","pubTime":"2025-11-26 10:16","pubTimestamp":1764123369,"startTime":"0","endTime":"0","summary":"消息面上，11月24日，绿叶制药发布公告，该集团自主研发的新一代5-羟色胺2A型受体反向激动剂和5-羟色胺2C型受体拮抗剂LY03017已获得美国食品药品监督管理局许可开展临床试验。LY03017拟用于治疗阿尔茨海默病精神病性障碍、帕金森病精神病性障碍、精神分裂症阴性症状。目前，LY03017也在中国处于Ⅰ期临床阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373709.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02186","BK1583","PDP","BK1191","BK1606"],"gpt_icon":0},{"id":"2585493593","title":"每日卖空追踪 | 绿叶制药 11月24日卖空量成交28.3万股，卖空比例为1.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585493593","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585493593?lang=zh_cn&edition=full","pubTime":"2025-11-24 16:30","pubTimestamp":1763973027,"startTime":"0","endTime":"0","summary":"绿叶制药北京时间11月24日，涨1.69%，卖空量成交28.3万股，较上一交易日减少93.31%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112416335195171b31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112416335195171b31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","BK1606","02186"],"gpt_icon":0},{"id":"2585204435","title":"绿叶制药(02186)新药LY03017在美国获准开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2585204435","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585204435?lang=zh_cn&edition=full","pubTime":"2025-11-24 08:05","pubTimestamp":1763942736,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿叶制药 公布，该集团自主研发的新一代5-羟色胺2A型受体反向激动剂和5-羟色胺2C型受体拮抗剂LY03017已获得美国食品药品监督管理局许可开展临床试验。LY03017基于集团的新分子实体╱新治疗实体技术平台开发，是集团又一款在中国和美国同步开发的中枢神经系统治疗领域创新药。目前，LY03017也在中国处于Ⅰ期临床阶段。临床前研究显示：LY03017的体内外药效活性、组织分布、心脏安全性均显著优于同目标适应症的已上市和在研药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1372500.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"绿叶制药(02186)新药LY03017在美国获准开展临床试验","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","02186","BK1191","BK1583"],"gpt_icon":0},{"id":"2585116447","title":"每日卖空追踪 | 绿叶制药 11月21日卖空量成交209.55万股，卖空比例为6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585116447","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585116447?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:30","pubTimestamp":1763713828,"startTime":"0","endTime":"0","summary":"绿叶制药北京时间11月21日，跌3.58%，卖空量成交209.55万股，较上一交易日增加5.94%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112116345797774c2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112116345797774c2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02186","BK1606","BK1583"],"gpt_icon":0},{"id":"2585116144","title":"绿叶制药11月21日遭主力抛售1260.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585116144","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585116144?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:15","pubTimestamp":1763712942,"startTime":"0","endTime":"0","summary":"11月21日, 绿叶制药股价跌3.58%，报收2.96元，成交金额1.0亿元，换手率0.85%，振幅4.23%，量比1.45。绿叶制药今日主力资金净流出1260.1万元，连续7日净流出，上一交易日主力净流出236.4万元。该股近5个交易日下跌6.29%，主力资金累计净流出3853.6万元；近20日主力资金累计净流入1934.9万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121161907951246cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121161907951246cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1606","02186","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.luye.cn","stockEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.087},{"period":"3month","weight":-0.1945},{"period":"6month","weight":-0.25},{"period":"1year","weight":0.1951},{"period":"ytd","weight":0.3548}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":-0.0351},{"period":"3month","weight":-0.0156},{"period":"6month","weight":0.0872},{"period":"1year","weight":0.2736},{"period":"ytd","weight":0.295}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"绿叶制药集团有限公司是一家主要从事药品的开发、生产、推广及销售的公司。该公司经营四个分部，包括肿瘤药物分部、心血管系统药物分部、消化与代谢药物分部和中枢神经系统药物分部。肿瘤药物分部提供力扑素、博优诺、百拓维、希美纳及米美欣等药品。心血管系统药物分部提供血脂康、欧开及麦通纳等药品。消化与代谢药物分部提供贝希等药品。中枢神经系统药物分部提供思瑞康、若欣林、瑞可妥、美比瑞及金悠平等药品。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.02774},{"month":2,"riseRate":0.363636,"avgChangeRate":0.023841},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.021667},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.009215},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.0086},{"month":6,"riseRate":0.363636,"avgChangeRate":0.035296},{"month":7,"riseRate":0.636364,"avgChangeRate":0.018026},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.044846},{"month":9,"riseRate":0.583333,"avgChangeRate":0.045957},{"month":10,"riseRate":0.5,"avgChangeRate":-0.00637},{"month":11,"riseRate":0.5,"avgChangeRate":0.024651},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.007274}],"exchange":"SEHK","name":"绿叶制药","nameEN":"LUYE PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"绿叶制药(02186)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供绿叶制药(02186)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"绿叶制药,02186,绿叶制药股票,绿叶制药股票老虎,绿叶制药股票老虎国际,绿叶制药行情,绿叶制药股票行情,绿叶制药股价,绿叶制药股市,绿叶制药股票价格,绿叶制药股票交易,绿叶制药股票购买,绿叶制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"绿叶制药(02186)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供绿叶制药(02186)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}